Journal of Virology, August 2002, p. 7724-7735, Vol. 76, No. 15
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.15.7724-7735.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Explant-Induced Reactivation of Herpes Simplex Virus Occurs in Neurons Expressing Nuclear cdk2 and cdk4
Luis M. Schang,* Andrew Bantly,,
and Priscilla A. Schaffer,
Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
Received 7 January 2002/
Accepted 22 April 2002
Herpes simplex virus (HSV) establishes productive (lytic) infections in nonneuronal cells and nonproductive (latent) infections in neurons. It has been proposed that HSV establishes latency because quiescent neurons lack cellular factors required for productive infection. It has been further proposed that these putative factors are induced following neuronal stress, as a requirement for HSV reactivation. To date, the identity of these putative cellular factors remains unknown. We have demonstrated that cyclin-dependent kinase (cdk) 1, 2, or 7 is required for HSV replication in nonneuronal cells. Interestingly, cdks 1 and 2 are not expressed in quiescent neurons but can be induced in stressed neurons. Thus, cdks may be among the cellular proteins required for HSV reactivation whose neuronal expression is differentially regulated during stress. Herein, we determined that neuronal expression of nuclear cdk2, cdk4, and cyclins E and D2 (which activate cdks 2 and 4, respectively) was induced following explant cultivation, a stressful stimulus that induces HSV reactivation. In contrast, neuronal expression of cdk7 and cytoplasmic cdk4 decreased during explant cultivation, whereas cdk3 was detected in the same small percentage of neurons before and after explant cultivation and cdks 1, 5, and 6 were not detected in neuronal cell bodies. HSV-1 reactivated specifically in neurons expressing nuclear cdk2 and cdk4, and an inhibitor specific for cdk2 inhibited HSV-1 reactivation. We conclude that neuronal levels of cdk2 are among the factors that determine the outcome of HSV infections of neurons.
* Corresponding author. Present address: Department of Biochemistry and Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada T6G 2HT. Phone: (780) 492-6265. Fax: (780) 492-3383. E-mail: luis.schang{at}ualberta.ca.
Present address: Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pa.
Present address: Department of Medicine, Harvard Medical School at the Beth Israel Deaconess Medical Center, Boston, MA 02215.
Journal of Virology, August 2002, p. 7724-7735, Vol. 76, No. 15
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.15.7724-7735.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Kolodkin-Gal, D., Zamir, G., Edden, Y., Pikarsky, E., Pikarsky, A., Haim, H., Haviv, Y. S., Panet, A.
(2008). Herpes Simplex Virus Type 1 Preferentially Targets Human Colon Carcinoma: Role of Extracellular Matrix. J. Virol.
82: 999-1010
[Abstract]
[Full Text]
-
Braun, E., Zimmerman, T., Hur, T. B., Reinhartz, E., Fellig, Y., Panet, A., Steiner, I.
(2006). Neurotropism of herpes simplex virus type 1 in brain organ cultures.. J. Gen. Virol.
87: 2827-2837
[Abstract]
[Full Text]
-
Habran, L., Bontems, S., Di Valentin, E., Sadzot-Delvaux, C., Piette, J.
(2005). Varicella-Zoster Virus IE63 Protein Phosphorylation by Roscovitine-sensitive Cyclin-dependent Kinases Modulates Its Cellular Localization and Activity. J. Biol. Chem.
280: 29135-29143
[Abstract]
[Full Text]
-
Diwan, P., Lacasse, J. J., Schang, L. M.
(2004). Roscovitine Inhibits Activation of Promoters in Herpes Simplex Virus Type 1 Genomes Independently of Promoter-Specific Factors. J. Virol.
78: 9352-9365
[Abstract]
[Full Text]
-
Sawtell, N. M., Thompson, R. L.
(2004). Comparison of Herpes Simplex Virus Reactivation in Ganglia In Vivo and in Explants Demonstrates Quantitative and Qualitative Differences. J. Virol.
78: 7784-7794
[Abstract]
[Full Text]
-
Taylor, S. L., Kinchington, P. R., Brooks, A., Moffat, J. F.
(2004). Roscovitine, a Cyclin-Dependent Kinase Inhibitor, Prevents Replication of Varicella-Zoster Virus. J. Virol.
78: 2853-2862
[Abstract]
[Full Text]
-
Li, Y.-H., Tao, P.-Z., Liu, Y.-Z., Jiang, J.-D.
(2004). Geldanamycin, a Ligand of Heat Shock Protein 90, Inhibits the Replication of Herpes Simplex Virus Type 1 In Vitro. Antimicrob. Agents Chemother.
48: 867-872
[Abstract]
[Full Text]
-
Davido, D. J., von Zagorski, W. F., Maul, G. G., Schaffer, P. A.
(2003). The Differential Requirement for Cyclin-Dependent Kinase Activities Distinguishes Two Functions of Herpes Simplex Virus Type 1 ICP0. J. Virol.
77: 12603-12616
[Abstract]
[Full Text]
-
Schang, L. M.
(2002). Cyclin-dependent kinases as cellular targets for antiviral drugs. J Antimicrob Chemother
50: 779-792
[Abstract]
[Full Text]
-
Schang, L. M., Bantly, A., Knockaert, M., Shaheen, F., Meijer, L., Malim, M. H., Gray, N. S., Schaffer, P. A.
(2002). Pharmacological Cyclin-Dependent Kinase Inhibitors Inhibit Replication of Wild-Type and Drug-Resistant Strains of Herpes Simplex Virus and Human Immunodeficiency Virus Type 1 by Targeting Cellular, Not Viral, Proteins. J. Virol.
76: 7874-7882
[Abstract]
[Full Text]
Copyright © 2002 by the American Society for Microbiology. All rights reserved.